Isomorphic Labs Raises $5 Billion for AI Drug Design

TLDR — Greenoaks and Sequoia co-led the Series C as Isomorphic prepares its first therapeutic programs for clinical trials, with Alphabet investing again....
Signal data─ Neutralconfidence 50%Low materiality
AssetEventsector-trendEvent timeAttention0 readers/hrNormalSmart readers0
Greenoaks and Sequoia co-led the Series C as Isomorphic prepares its first therapeutic programs for clinical trials, with Alphabet investing again.... Read the full story at The Defiant
0 impressions · 0 upvotes · 0 comments
Discussion (0)
Reading is open to everyone — posting, replying and reporting need an account.
No comments yet.